Oxygen Doesn't Reduce Mortality in Suspected Acute MI

This article originally appeared here.
Share this content:
Oxygen Doesn't Reduce Mortality in Suspected Acute MI
Oxygen Doesn't Reduce Mortality in Suspected Acute MI

TUESDAY, Aug. 29, 2017 (HealthDay News) -- For patients with suspected acute myocardial infarction without hypoxemia, routine use of supplemental oxygen does not reduce one-year all-cause mortality, according to a study published online Aug. 28 in the New England Journal of Medicine. The research was published to coincide with the European Society of Cardiology Congress 2017, held from Aug. 26 to 30 in Barcelona, Spain.

Robin Hofmann, M.D., from the Karolinska Institutet in Stockholm, and colleagues enrolled 6,629 patients with suspected myocardial infarction and oxygen saturation of 90 percent or higher. Participants were randomized to receive supplemental oxygen or ambient air.

The researchers found that the median duration of oxygen therapy was 11.6 hours, and the median oxygen saturation at the end of the treatment period was 99 and 97 percent among patients assigned to oxygen and ambient air, respectively. Hypoxemia developed in 1.9 and 7.7 percent of patients in the oxygen and ambient air groups, respectively. The median of the highest troponin level during hospitalization was 946.5 and 983.0 ng/L in the oxygen and ambient-air groups, respectively. Death from any cause within one year of randomization occurred in 5.0 and 5.1 percent of patients in the oxygen and ambient air groups, respectively (hazard ratio, 0.97; 95 percent confidence interval, 0.79 to 1.21; P = 0.80).

"Routine use of supplemental oxygen in patients with suspected myocardial infarction who did not have hypoxemia was not found to reduce one-year all-cause mortality," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »